Chemerin levels have also been shown to be higher in obesity, some features of MetS, diabetes, and nonalcoholic fatty liver disease [46–48], and it appears to induce insulin resistance in skeletal muscle, the major site of peripheral insulin resistance [49]. The gene discussed is RARRES2; the disease is metabolic syndrome.